Sign in
Taking people in United StatesNo phase

Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction

Key facts

Who runs it
Comphya Inc.
Where
Baltimore, United StatesSee the site
Trial code
Status
Recruiting
People taking part
20 people, planned
Started
5 Jun 2025
Expected to end
Apr 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Activation of pro-erectile nerves within the pelvic plexus
Record updated
10 November 2025

Who can take part

Age
30 years to 75 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Men of ages between 30-75 years with indication for nerve-sparing prostatectomy surgery
  • Cancer stage T1c and T2a
  • Grade Groups 1 and 2 as well as low volume Grade Group 3 (Gleason score 4 + 3 = 7), as determined by biopsy (2 cores or less GG3) or single index MRI lesion of GG3 disease
  • IIEF-15 erectile function domain score equal to or greater than 26
  • Men interested in minimizing the effect of radical prostatectomy on erectile function
  • Ability to read and understand patient information materials and willingness to sign a written informed consent

Who cannot take part

  • History of previous pelvic surgery, trauma or irradiation therapy
  • Patient is currently participating in another clinical investigation that would serve as a contraindication to implant a neurostimulator device to augment erectile function
  • Have participated in any drug or device trial in the last 4 weeks or plan to participate in any other drug or device study during the next 24 months
  • Men with neurological disease, including a history of spinal cord injury or trauma
  • Failure to demonstrate adequate nocturne erectile function prioi prostatectomy (nocturnal RigiScan measure)
  • History of ED, priapism and Peyronie disease
  • Patient diagnosed with neurologic degenerative diseases that may negatively impact erectile functions
  • Patients with insulin-dependent diabetes who suffer peripheral neuropathy or other diabetes associated complications
  • IIEF-15 erectile function domain score less than 26
  • Men with PSA > 20 ng/mL
  • Currently have an active implantable device
  • Identification of technical or clinical limitation to properly apply the use of nerve-sparing techniques during operation
  • Inability to understand and demonstrate device use instructions
  • Patient unwillingness to engage in sexual activity
  • Possess any other characteristics that, per the investigator's judgment, may increase the risk or impair data collection for the procedure/study
  • Patient is a member of a vulnerable population (Vulnerable participants include those who lack consent capacity, including the mentally ill, prisoners, cognitively impaired participants, and employee volunteers)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 30 and 75 years old?

Where in United States

  • Johns Hopkins HospitalBaltimore, United StatesContact: Rana HarbTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to assess if a new device is safe to use as a potential treatment for erectile dysfunction following radical prostatectomy.

Read full original descriptionShow less

The main questions it aims to answer are:

* Is the device safe? * Does the device works well? Are the participants satisfied with the device?

Participants will be implanted with the device during the ongoing prostatectomy surgery and will be asked to complete the following tasks during 6 months follow-up:

* Come to the hospital for follow-up visits, * Complete questionnaires, * Activate the device every day, * Measure erection hardness.

Researchers will compare an implanted group (participants having the device) with a control group (participants not having the device) to see if the device works well.

The 2 groups in the trial

  • Implanted groupTreatment being tested

    Participants in the implanted group will be implanted with the study device during ongoing prostatectomy surgery.

    Treatment: Activation of pro-erectile nerves within the pelvic plexus

  • Control groupNo study treatment, for comparison

    Participants in the control group will undergo standard prostatectomy and will not be implanted with the study device.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Safety and Tolerability of a Novel Implantable Device for the Treatment of Erectile Dysfunction Following Radical Prostatectomy
Fit questions
Built from NCT06968494, who can take part
Record updated
10 November 2025